Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Pizzimenti

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Cells|April 12, 2024
Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target GliomasChiara Dianzani, Annalisa Bozza, Valentina Bordano, et al.
Anti-Cancer Drugs|May 29, 2004
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cellsLoredana Serpe, Stefano Laurora, Stefania Pizzimenti, et al.
Cancer Research|November 15, 2015
Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast CancerStefania Lanzardo, Laura Conti, Ronald Rooke, et al.
Pharmaceutics|May 27, 2023
Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to MelanomaFederica Foglietta, Annalisa Bozza, Chiara Ferraris, et al.
Free Radical Biology & Medicine|November 25, 2017
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation diseaseCinzia Antognelli, Eliana Trapani, Simona Delle Monache, et al.
Free Radical Biology & Medicine|November 17, 2010
Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cellsPiergiorgio Pettazzoni, Stefania Pizzimenti, Cristina Toaldo, et al.
Journal of Biomedical Nanotechnology|June 16, 2016
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate CancerCasimiro Luca Gigliotti, Rosalba Minelli, Roberta Cavalli, et al.
Atherosclerosis|July 6, 2011
PPARγ in coronary atherosclerosis: in vivo expression pattern and correlations with hyperlipidemic status and statin treatmentAngela Pucci, Luisa Formato, Maruska Muscio, et al.
Free Radical Biology & Medicine|May 18, 2016
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defensesMartina Daga, Chiara Ullio, Monica Argenziano, et al.
The Biochemical Journal|June 3, 2026
Correction: Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with α-enolase devoid of plasminogen binding activityGiuseppina Barrera, Fabrizio Gentile, Stefania Pizzimenti, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Cells|April 12, 2024
Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target GliomasChiara Dianzani, Annalisa Bozza, Valentina Bordano, et al.
Anti-Cancer Drugs|May 29, 2004
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cellsLoredana Serpe, Stefano Laurora, Stefania Pizzimenti, et al.
Cancer Research|November 15, 2015
Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast CancerStefania Lanzardo, Laura Conti, Ronald Rooke, et al.
Pharmaceutics|May 27, 2023
Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to MelanomaFederica Foglietta, Annalisa Bozza, Chiara Ferraris, et al.
Free Radical Biology & Medicine|November 25, 2017
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation diseaseCinzia Antognelli, Eliana Trapani, Simona Delle Monache, et al.
Free Radical Biology & Medicine|November 17, 2010
Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cellsPiergiorgio Pettazzoni, Stefania Pizzimenti, Cristina Toaldo, et al.
Journal of Biomedical Nanotechnology|June 16, 2016
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate CancerCasimiro Luca Gigliotti, Rosalba Minelli, Roberta Cavalli, et al.
Atherosclerosis|July 6, 2011
PPARγ in coronary atherosclerosis: in vivo expression pattern and correlations with hyperlipidemic status and statin treatmentAngela Pucci, Luisa Formato, Maruska Muscio, et al.
Free Radical Biology & Medicine|May 18, 2016
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defensesMartina Daga, Chiara Ullio, Monica Argenziano, et al.
The Biochemical Journal|June 3, 2026
Correction: Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with α-enolase devoid of plasminogen binding activityGiuseppina Barrera, Fabrizio Gentile, Stefania Pizzimenti, et al.
Pageof 8